Pfizer SG&A Expense (Quarterly) Trends

Pfizer Inc (PFE)

25.42 -0.27 (-1.05%) USD | NYSE | Apr 17, 16:00

25.42 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1990. Upgrade now.

Date	Value
December 31, 2023	4.575B
September 30, 2023	3.281B
June 30, 2023	3.497B
March 31, 2023	3.418B
December 31, 2022	4.645B
September 30, 2022	3.391B
June 30, 2022	3.048B
March 31, 2022	2.593B
December 31, 2021	4.104B
September 30, 2021	2.899B
June 30, 2021	2.923B
March 31, 2021	2.777B
December 31, 2020	3.739B
September 30, 2020	2.658B
June 30, 2020	2.659B
March 31, 2020	2.541B
December 31, 2019	2.616B
September 30, 2019	3.26B
June 30, 2019	3.511B
March 31, 2019	3.339B
December 31, 2018	2.164B
September 30, 2018	3.494B
June 30, 2018	3.542B
March 31, 2018	3.412B
December 31, 2017	4.555B

Date	Value
September 30, 2017	3.504B
June 30, 2017	3.43B
March 31, 2017	3.315B
December 31, 2016	4.43B
September 30, 2016	3.559B
June 30, 2016	3.471B
March 31, 2016	3.385B
December 31, 2015	5.048B
September 30, 2015	3.27B
June 30, 2015	3.386B
March 31, 2015	3.104B
December 31, 2014	3.981B
September 30, 2014	3.556B
June 30, 2014	3.52B
March 31, 2014	3.04B
December 31, 2013	4.152B
September 30, 2013	3.395B
June 30, 2013	3.591B
March 31, 2013	3.217B
December 31, 2012	4.337B
September 30, 2012	3.491B
June 30, 2012	3.665B
March 31, 2012	3.968B
December 31, 2011	3.946B
September 30, 2011	4.457B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.541B

Minimum

Mar 2020

4.645B

Maximum

Dec 2022

3.270B

Average

3.26B

Median

Sep 2019

SG&A Expense (Quarterly) Benchmarks